Showing results (1421-1430 of 1,513) with videos related to
Sort By:
Pageof 152
Tissue Engineering. Part C, Methods|October 16, 2015
Functional Heart Valve Scaffolds Obtained by Complete Decellularization of Porcine Aortic Roots in a Novel Differential Pressure Gradient Perfusion SystemLeslie Neil Sierad, Eliza Laine Shaw, Alexander Bina, et al.The Medical Journal of Australia|December 5, 2021
Care of older people and people requiring palliative care with COVID-19: guidance from the Australian National COVID-19 Clinical Evidence TaskforceSaskia Cheyne, Richard I Lindley, Natasha Smallwood, et al.Journal of Medicinal Chemistry|October 3, 2003
Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulantsPatrick Y S Lam, Charles G Clark, Renhua Li, et al.Communications Psychology|January 22, 2025
Self-reports map the landscape of task states derived from brain imagingBrontë Mckeown, Ian Goodall-Halliwell, Raven Wallace, et al.Bioorganic & Medicinal Chemistry Letters|November 3, 2007
Investigation of the terminal P4 domain in a series of D-phenylglycinamide-based factor Xa inhibitorsJeffry B Franciskovich, John J Masters, Wayne W Weber, et al.Science (New York, N.Y.)|January 16, 2010
The genetic map of Artemisia annua L. identifies loci affecting yield of the antimalarial drug artemisininIan A Graham, Katrin Besser, Susan Blumer, et al.Nature|December 13, 2019
Multi-omics profiling of mouse gastrulation at single-cell resolutionRicard Argelaguet, Stephen J Clark, Hisham Mohammed, et al.Elife|January 10, 2025
Mapping patterns of thought onto brain activity during movie-watchingRaven Star Wallace, Bronte Mckeown, Ian Goodall-Halliwell, et al.Lancet (London, England)|May 27, 2014
Euro 2012 European Football Championship Finals: planning for a health legacyCatherine A H Smallwood, Katherine G Arbuthnott, Barbara Banczak-Mysiak, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2006
1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor XaDonald J P Pinto, Michael J Orwat, Mimi L Quan, et al.Pageof 152